Isabel Kalofonos
Chief Commercial Officer · 2 filings · Latest: Sep 1, 2026
Crinetics Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CRNX | ISABEL KALOFONOS | — | Jan 5, 2026 | Proposed Sale | $46.73 | 2,500 | $116.8K | — |